Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Atropine for Sympathetic Blockade in C-Section
NCT05892913Phase 4Completed
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Jul 2023
- Primary completion
- Oct 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in hypotension and bradycardia (2 arms), sponsored by Bolu Abant Izzet Baysal University. Primary endpoints: Heart Rate, Systolic Blood Pressure and 3 more. Started Jul 2023; status: completed.
02
Drugs
atropine
03
Conditions
hypotensionbradycardia
Beyond the preview
Go deeper on NCT05892913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05892913.